<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03519763</url>
  </required_header>
  <id_info>
    <org_study_id>1707-ABU-065-HF</org_study_id>
    <nct_id>NCT03519763</nct_id>
  </id_info>
  <brief_title>Intrauterine Microbiota During IVF in Patients Affected With Isthmocele.</brief_title>
  <official_title>Endometrial and Isthmic Microbiota During IVF Stimulation in Patients Affected With Isthmocele and Intrauterine Mucus Secretion After C-section.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IVI Middle East Fertility Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IVI Middle East Fertility Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the endometrial and isthmic microbiota in patients with isthmocele after
      C-Section, and if this microbiota is similar or not with better reproductive outcomes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A total of 45 subjects undergoing in vitro fertilization treatment. Fifteen patients without
      isthmocele will be included in the control group and 30 patients affected with isthmocele in
      the other group, divided in 2 subgroups: 15 with 1 previous C-Section, and 15 with 2 or more
      previous C-Section. Paired samples of endometrial fluid (EF) and isthmic fluid (IF) will be
      obtained simultaneously the day of egg retrieval. Patients will follow a protocol for
      all-freezing embryos or oocytes.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 2018</start_date>
  <completion_date type="Anticipated">April 2019</completion_date>
  <primary_completion_date type="Anticipated">January 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>If the intrauterine microbiota profile in patients affected with isthmocele differs from the one found in patients without isthmocele.</measure>
    <time_frame>1year</time_frame>
    <description>patients undergoing in vitro fertilization treatment</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">3</enrollment>
  <condition>Endometrial Diseases</condition>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <description>Fifteen patients without isthmocele</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Study subgroup1</arm_group_label>
    <description>15 patients with 1 previous C-Section</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Study subgroup2</arm_group_label>
    <description>15 patients with 2 or more previous C-Section.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>ultrasound</intervention_name>
    <description>All the patients will have a transvaginal ultrasound evaluation during the first visit to the clinic to evaluate the presence or not of isthmocele.</description>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_label>Study subgroup2</arm_group_label>
    <other_name>transvaginal scan, ultrasound</other_name>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      samples for Endometrial fluid (EF) and isthmocele fluid (IF) will be collected the day of the
      oocyte pick up after IVF stimulation for freeze-all oocytes or embryos.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Female patients undergoing IVF treatment.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients with isthmocele:

               -  Patients performing IVF treatment with a planned cycle segmentation and
                  consecutive frozen embryo transfer on a hormone replacement therapy (HRT) cycle
                  or natural cycle.

               -  Age between 18 - 45 years all (both inclusive).

               -  One or multiple C-sections.

               -  Isthmocele present during TV scan.

               -  BMI: 18,5 - 35 kg / m2 (both inclusive).

          2. Patients without isthmocele:

               -  Patients performing IVF treatment with planned cycle segmentation and who would
                  have embryo transfer with frozen embryos under hormone replacement therapy.

               -  NO Isthmocele present during transvaginal ultrasound.

               -  BMI: 18,5 - 30 kg / m2 (both inclusive).

        Exclusion Criteria:

          -  Age &lt; 18 and &gt; 45 years old.

          -  Previous or active endometritis.

          -  Patients who are IUD carriers for the last 3 months.

          -  Patients who have taken prescribed antibiotics in the last 3 months previous to sample
             collection.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Human Fatemi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical Director</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>laura melado, MD</last_name>
    <phone>02 652 8000</phone>
    <email>laura.melado@ivirma.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Barbara Lawrenz, MD</last_name>
    <phone>02 652 8000</phone>
    <email>barbara.lawrenz@ivirma.com</email>
  </overall_contact_backup>
  <reference>
    <citation>Sirota I, Zarek SM, Segars JH. Potential influence of the microbiome on infertility and assisted reproductive technology. Semin Reprod Med. 2014 Jan;32(1):35-42. doi: 10.1055/s-0033-1361821. Epub 2014 Jan 3. Review.</citation>
    <PMID>24390919</PMID>
  </reference>
  <reference>
    <citation>Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SS, McCulle SL, Karlebach S, Gorle R, Russell J, Tacket CO, Brotman RM, Davis CC, Ault K, Peralta L, Forney LJ. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4680-7. doi: 10.1073/pnas.1002611107. Epub 2010 Jun 3.</citation>
    <PMID>20534435</PMID>
  </reference>
  <reference>
    <citation>Romero R, Hassan SS, Gajer P, Tarca AL, Fadrosh DW, Bieda J, Chaemsaithong P, Miranda J, Chaiworapongsa T, Ravel J. The vaginal microbiota of pregnant women who subsequently have spontaneous preterm labor and delivery and those with a normal delivery at term. Microbiome. 2014 May 27;2:18. doi: 10.1186/2049-2618-2-18. eCollection 2014.</citation>
    <PMID>24987521</PMID>
  </reference>
  <reference>
    <citation>Moreno I, Codoñer FM, Vilella F, Valbuena D, Martinez-Blanch JF, Jimenez-Almazán J, Alonso R, Alamá P, Remohí J, Pellicer A, Ramon D, Simon C. Evidence that the endometrial microbiota has an effect on implantation success or failure. Am J Obstet Gynecol. 2016 Dec;215(6):684-703. doi: 10.1016/j.ajog.2016.09.075. Epub 2016 Oct 4.</citation>
    <PMID>27717732</PMID>
  </reference>
  <reference>
    <citation>Tower AM, Frishman GN. Cesarean scar defects: an underrecognized cause of abnormal uterine bleeding and other gynecologic complications. J Minim Invasive Gynecol. 2013 Sep-Oct;20(5):562-72. doi: 10.1016/j.jmig.2013.03.008. Epub 2013 May 14. Review.</citation>
    <PMID>23680518</PMID>
  </reference>
  <reference>
    <citation>Vikhareva Osser O, Valentin L. Risk factors for incomplete healing of the uterine incision after caesarean section. BJOG. 2010 Aug;117(9):1119-26. doi: 10.1111/j.1471-0528.2010.02631.x.</citation>
    <PMID>20604776</PMID>
  </reference>
  <reference>
    <citation>Sim K, Cox MJ, Wopereis H, Martin R, Knol J, Li MS, Cookson WO, Moffatt MF, Kroll JS. Improved detection of bifidobacteria with optimised 16S rRNA-gene based pyrosequencing. PLoS One. 2012;7(3):e32543. doi: 10.1371/journal.pone.0032543. Epub 2012 Mar 28.</citation>
    <PMID>22470420</PMID>
  </reference>
  <reference>
    <citation>Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Peña AG, Goodrich JK, Gordon JI, Huttley GA, Kelley ST, Knights D, Koenig JE, Ley RE, Lozupone CA, McDonald D, Muegge BD, Pirrung M, Reeder J, Sevinsky JR, Turnbaugh PJ, Walters WA, Widmann J, Yatsunenko T, Zaneveld J, Knight R. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010 May;7(5):335-6. doi: 10.1038/nmeth.f.303. Epub 2010 Apr 11.</citation>
    <PMID>20383131</PMID>
  </reference>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 25, 2018</study_first_submitted>
  <study_first_submitted_qc>May 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 9, 2018</study_first_posted>
  <last_update_submitted>May 8, 2018</last_update_submitted>
  <last_update_submitted_qc>May 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>IVI Middle East Fertility Clinic</investigator_affiliation>
    <investigator_full_name>Prof Dr. Human Fatemi</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Uterine Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

